These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 3060147)
1. Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI). Fritz H Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():79-82. PubMed ID: 3060147 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin. Walter M; Plotnick M; Schechter NM Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699 [TBL] [Abstract][Full Text] [Related]
3. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor. Wright CD; Kennedy JA; Zitnik RJ; Kashem MA Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787 [TBL] [Abstract][Full Text] [Related]
6. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase. van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241 [TBL] [Abstract][Full Text] [Related]
8. Identification of SLPI (secretory leukocyte protease inhibitor) in human mast cells using immunohistochemistry and in situ hybridisation. Westin U; Polling A; Ljungkrantz I; Ohlsson K Biol Chem; 1999 Apr; 380(4):489-93. PubMed ID: 10355635 [TBL] [Abstract][Full Text] [Related]
9. Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization. Ohlsson K; Bjartell A; Lilja H J Androl; 1995; 16(1):64-74. PubMed ID: 7539415 [TBL] [Abstract][Full Text] [Related]
10. Interaction of secretory leukocyte protease inhibitor with proteinase-3. Rao NV; Marshall BC; Gray BH; Hoidal JR Am J Respir Cell Mol Biol; 1993 Jun; 8(6):612-6. PubMed ID: 8100709 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin. Boudier C; Cadène M; Bieth JG Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091 [TBL] [Abstract][Full Text] [Related]
12. The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses. Kido H; Beppu Y; Imamura Y; Chen Y; Murakami M; Oba K; Towatari T Biopolymers; 1999; 51(1):79-86. PubMed ID: 10380355 [TBL] [Abstract][Full Text] [Related]
13. Analysis of secretory leukocyte protease inhibitor (SLPI) in bronchial secretions from patients with hypersecretory respiratory diseases. Kouchi I; Yasuoka S; Ueda Y; Ogura T Tokushima J Exp Med; 1993 Jun; 40(1-2):95-107. PubMed ID: 8105562 [TBL] [Abstract][Full Text] [Related]
14. IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release. Westin U; Lundberg E; Ohlsson K Mediators Inflamm; 1998; 7(3):217-20. PubMed ID: 9705610 [TBL] [Abstract][Full Text] [Related]
15. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis. Cox SW; Rodriguez-Gonzalez EM; Booth V; Eley BM J Periodontal Res; 2006 Oct; 41(5):477-85. PubMed ID: 16953825 [TBL] [Abstract][Full Text] [Related]
16. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family. Moreau T; Baranger K; Dadé S; Dallet-Choisy S; Guyot N; Zani ML Biochimie; 2008 Feb; 90(2):284-95. PubMed ID: 17964057 [TBL] [Abstract][Full Text] [Related]
17. Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cells. Nyström M; Bergenfeldt M; Ljungcrantz I; Lindeheim A; Ohlsson K Mediators Inflamm; 1999; 8(3):147-51. PubMed ID: 10704052 [TBL] [Abstract][Full Text] [Related]
18. Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa. Nyström M; Westin UP; Linder C; Ohlsson K Mediators Inflamm; 2001 Oct; 10(5):269-72. PubMed ID: 11759111 [TBL] [Abstract][Full Text] [Related]
19. The mucosal defence capacity against proteolytic leukocyte enzymes. Tegner H; Fryksmark U; Ohlsson K Eur J Respir Dis Suppl; 1985; 139():62-5. PubMed ID: 3876236 [TBL] [Abstract][Full Text] [Related]
20. Intratracheally-instilled antileukoprotease and alpha 1-proteinase inhibitor: effect on human neutrophil elastase-induced experimental emphysema and pulmonary localization. Rudolphus A; Kramps JA; Mauve I; Dijkman JH Histochem J; 1994 Oct; 26(10):817-24. PubMed ID: 7883591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]